Market Analysis
published on Sep 15, 2022
Report Overview:
NelsonHall’s analysis of the impact of the economic downturn on the Pharmaceuticals sector consists of 13 pages. This is one of a series of industry sector reports assisting buyers and suppliers to monitor the impact of recent changes in the socioeconomic environment.
Who is this Report for:
NelsonHall’s “Impact of Economic Downturn on the Pharmaceuticals Sector” report is a survey of CFOs in pharmaceutical firms to ascertain the extent and nature of the impact of the post-COVID economic downturn on the sector. In particular, the report identifies the impact on short-term pharmaceutical sector financials, enterprise and IT strategies, and operational transformation priorities. The report is designed for:
- Vendor marketing, sales, and business managers wishing to understand the impact of the post-COVID economic downturn on pharmaceutical firms’ operations transformation priorities
- Pharmaceutical executives interested in understanding the impact of the post-COVID economic downturn on their peers
- Financial analysts and investors specializing in the services sector who are looking to understand the impact of the post-COVID economic downturn on the pharmaceutical sector’s IT and operational transformation strategies.
Scope of this Report:
The report analyzes the worldwide impact of the post-COVID economic downturn on pharmaceutical firms and addresses the following questions:
- What is the expected change in pharmaceutical sector revenues & costs in Q3 2022?
- By what percentage will each functional budget be impacted over the next 12 months?
- What approaches to the anticipated rise in inflation will be favored by the pharmaceutical sector?
- What impact will the economic downturn have on enterprise strategy in the pharmaceutical sector?
- What are the key priorities for operational transformation planned by pharmaceutical firms over the next 12 months?
- In which process areas are pharmaceutical firms likely to increase their use of outsourcing to achieve greater operational resilience or address personnel shortages?
- What impact will the economic downturn have on enterprise IT strategy in the pharmaceutical sector?
- What changes are expected in external IT services spending over the next 12 months?
Key Findings & Highlights:
NelsonHall’s analysis of the Impact of the Economic Downturn on the Pharmaceutical Sector consists of 13 pages. The report focuses on identifying the changes in priority within enterprise strategy, IT strategy, operational transformation, and business process outsourcing, together with forecast changes in functional budgets and IT services spend over the next 12 months.
This report is one of a series of detailed individual sector reports published by NelsonHall.